Søgning på udtrykket 'corona' giver 50 resultater


Dokumenter [6] Kalender [4] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [6]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Ændringer siden version 28: Moderat risikogruppe udgår. Gravide udgår som risikogruppe. Skærpelse af kriterier for opstart af Paxlovid (nu kun højrisiko patient med indikation).

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.


Kalender [4]

2. juni 2023, Auditorium 3 og 4, Hvidovre Hospital
12. september 2022, Novo Nordisk Fonden, Hellerup
2. juni 2022, Auditorium 93, Rigshospitalet

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
15.10.2024
. Objective. This study aimed to evaluate the impact of the COVID-19 pandemic on the management of acute coronary syndrome (ACS) in Yogyakarta, Indonesia with respect to time to treatment, treatment pattern and treatment outcome. . Design. This is a retrospective cohort study in which medical records of hospitalised patients with ACS were reviewed. . Setting. Three hospitals in Yogyakarta, Indonesia. . Participants. Patients hospitalised with ACS during two pandemic periods (first pandemic period: March…
BMC Infectious Diseases
28.09.2024
. Abstract. . Background. SARS-CoV-2, the causative agent of COVID-19, is a betacoronavirus belonging to the same genus as endemic human coronaviruses (hCoVs) OC43 and HKU1 and is distinct from alpha hCoVs 229E and NL63. In a study of adolescents in the Philippines, we evaluated seroprevalence to the hCoVs, whether pre-pandemic hCoV immunity modulated subsequent risk of SARS-CoV-2 infection, and if SARS-CoV-2 infection affe…
Journal of Medical Virology
18.09.2024
Journal of Medical Virology, Volume 96, Issue 9, September 2024.
BMC Infectious Diseases
15.09.2024
. Abstract. . Background. Even though the disease has spread throughout the world, with millions killed, global COVID-19 vaccination coverage remains low, particularly in developing countries. However, epidemiological data is lacking in the area. Hence, this study aimed to assess COVID-19 uptake, willingness for vaccination, and associated factors. . . . Method. …
Proceedings of the National Academy of Sciences
4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Proceedings of the National Academy of Sciences
7.08.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 32, August 2024.
International Journal of Infectious Diseases
4.08.2024
…and plants [1]. The clinical manifestations of BCC vary extensively, ranging from asymptomatic to severe lower respiratory infections, such as cystic fibrosis (CF) and chronic granulomatous disease, or bloodstream infection in immunocompromised patients [1,2]; however, central nervous system (CNS) infections caused by BCC are rare. We present a case of choroid plexitis due to refractory BCC following coronavirus disease 2019 (COVID-19) that was successfully treated with a long-term, multiantibiotic regimen.
International Journal of Infectious Diseases
2.08.2024
The COVID-19 pandemic has been an unprecedented challenge for global public health; worldwide, more than 774 million confirmed cases and more than 7 million deaths have been reported as of March 2024. The Americas region has been one of the hardest hit, with 43% of deaths reported globally and more than 3 million deaths to date [1].
BMC Infectious Diseases
30.07.2024
… High Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), Platelet-to-Lymphocyte Ratio (PLR) were associated with worse prognosis of patients with sepsis. In-hospital mortality has been reported to be higher in patients with coronary artery disease (CAD) and sepsis than those with sepsis alone. However, the relationship between NLR, MLR, PLR and mortality in septic patients with coronary artery disease (CAD) remains unclear. The study aimed to explore the association between N…
Journal of Medical Virology
21.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Clinical Infectious Diseases
19.07.2024
Abstract . Background . Reliable biomarkers of coronavirus disease 2019 (COVID-19) outcomes are critically needed. We evaluated associations of spike antibody (Ab) and plasma nucleocapsid antigen (N Ag) with clinical outcomes in nonhospitalized persons with mild-to-moderate COVID-19.Methods . Participants were nonhospitalized adults with mild-to-moderate COVID-19 enrolled in ACTIV-2 between January and July 2021 and randomized to placebo. We used quantitative assays for severe acute respiratory syndrome cor…
PLoS One Infectious Diseases
19.07.2024
by Ahd A. Mansour, Sarah M. Hussein, Shatha G. Felemban, Adib W. Mahamid .
BMC Infectious Diseases
17.07.2024
. Abstract. . Background. Corona virus disease 2019 (COVID-19) is an extremely contagious viral infection caused by the severe acute respiratory syndrome coronavirus 2. Understanding the willingness of the community to receive the COVID-19 vaccine will help in the development and implementation of effective COVID-19 vaccination promotion programs. Therefore, we aimed to assess the level of COVID-19 vaccine acceptance and ass…
PLoS One Infectious Diseases
17.07.2024
by Luying Chen, Lulu Dai, Jiawei Xu, Lian Duan, Xiaoxia Hou, Lu Zhang, Libo Song, Fangfang Zhao, Yuerong Jiang . Introduction Despite the available secondary preventive treatments, the management of stable coronary artery disease (SCAD) remains challenging. Intermediate coronary lesion (ICL), defined as luminal stenosis between 50% and 70%, is a key stage of SCAD. However, existing therapeutic strategies are limitated in delaying plaque progression and associated with various adverse effects and economic b…
BMC Infectious Diseases
12.07.2024
. Abstract. . Background. Corona virus disease 2019 (COVID-19) is an extremely contagious viral infection caused by the severe acute respiratory syndrome coronavirus 2. Understanding the willingness of the community to receive the COVID-19 vaccine will help in the development and implementation of effective COVID-19 vaccination promotion programs. Therefore, we aimed to assess the level of COVID-19 vaccine acceptance and ass…
Clinical Infectious Diseases
11.07.2024
Abstract . Background . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) down-regulates angiotensin-converting enzyme 2, potentially increasing angiotensin II. We hypothesized that losartan compared to usual care decreases mortality and is safe in patients hospitalized with coronavirus disease 2019 (COVID-19). We aimed to evaluate the effect of losartan versus usual care on 28-day mortality in patients hospitalized for acute COVID-19.Methods . Eligibility criteria included adults admitted for ac…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
5.10.2024
How should doctors and patients approach SARS-CoV-2 testing when the prevalence of acute respiratory diseases is high? . Medscape Medical News
Medscape Infectious Diseases
24.10.2023
Evidence showing the SARS-CoV-2 virus directly infects coronary atherosclerotic plaques, causing a persistent inflammatory response, may lead to new approaches for managing patients after infection. . Medscape Medical News
Medscape Infectious Diseases
29.09.2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is found in coronary arteries of patients who died of COVID-19. . Medscape Medical News
ECDC COVID-19 updates
23.08.2023
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
ECDC COVID-19 updates
15.12.2022
This Reporting Protocol provides guidelines for data managers in reporting countries on how to prepare data for submission to TESSy, deadlines for reporting, subject-specific information (e.g. new changes to metadata), and links to further information.
Medscape Infectious Diseases
12.10.2022
Long COVID may be an unusual response to previously encountered non-SARS-CoV-2 coronaviruses, researchers report. .
Medscape Infectious Diseases
11.10.2022
Digital spatial transcriptomic profiling of coronary endothelial cells shows differential expression patterns for SARS-CoV-2 myocarditis. .
Medscape Infectious Diseases
30.08.2022
Antigen levels could potentially be used to predict which patients may have a higher risk of more severe COVID-19, as well as who could benefit from certain treatments. .
Medscape Infectious Diseases
26.08.2022
Jill Biden, 71, first tested positive for the coronavirus on August 16. She began a course of Paxlovid. She has been double-vaccinated and boosted twice. .
Medscape Infectious Diseases
30.06.2022
"I applaud the sentiment that is long overdue," said Eric Topol, MD. "It is crucial that we get ahead of the virus, and the best way is to develop pan-betacoronavirus vaccines that are variant-proof." .
Statens Serum Institut
18.05.2022
Fredag den 20. maj vil man kortvarigt ikke kunne se nye covid-19-prøvesvar i coronapasset. Men alle borgere kan se deres prøvesvar på sundhed.dk. Dette skyldes en større flytning af produktionsservere hos Statens Serum Institut.
Eurosurveillance latest updates
5.05.2022
…-2 infection against symptomatic infection by BA.2 or other variants. . . Methods. Using 50% plaque reduction neutralisation tests (PRNT50), we assessed neutralising antibody titres to BA.2, wild type (WT) SARS-CoV-2 and other variants in Comirnaty or CoronaVac vaccinees, with or without prior WT-SARS-CoV-2 infection. Titres were also measured for non-vaccinees convalescing from a WT-SARS-CoV-2 infection. Neutralising antibodies in BA.2 and BA.1 breakthrough infections and in BA.2 infections affecting n…
Medscape Infectious Diseases
1.04.2022
The legislation would have made public and private employers subject to a misdemeanor charge punishable by a $1,000 fine if they require vaccines as a condition of employment or service. .
Statens Serum Institut
22.03.2022
Siden november sidste år kan op mod 70 procent af voksne danskere mellem 17 og 72 år have været smittet med SARS-CoV-2. Det viser resultater fra den nyeste runde af undersøgelsen af blod fra landets bloddonorer.
Medscape Infectious Diseases
8.03.2022
The on-off nature of the pandemic "has led to a lot of the confusion and grumpiness," says one expert. .
Medscape Infectious Diseases
7.03.2022
Vaccines that target multiple coronaviruses at once based on common elements are in the works to help dampen future pandemics. .
Medscape Infectious Diseases
25.02.2022
"People want to live freely in Florida, without corporate masking creating a two-tier society and without overbearing isolation for children," DeSantis said in a statement. .
Eurosurveillance latest updates
13.01.2022
The mRNA vaccine Comirnaty and the inactivated vaccine CoronaVac are both available in Hong Kong’s COVID-19 vaccination programme. We observed waning antibody levels in 850 fully vaccinated (at least 14 days passed after second dose) blood donors using ELISA and surrogate virus neutralisation test. The Comirnaty-vaccinated group’s (n = 593) antibody levels remained over the ELISA and sVNT positive cut-offs within the first 6 months. The CoronaVac-vaccinated group’s (n =&#…
Medscape Infectious Diseases
28.12.2021
The coronavirus that causes COVID-19 can spread to the heart and brain within days of infection and can survive for months in organs, according to a new study by the National Institutes of Health. .
Medscape Infectious Diseases
27.12.2021
A recent fourfold increase in pediatric hospital admissions began the week of December 5. The NY state health commissioner is urging parents to get kids 5 and older vaccinated and have them wear masks. .

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.14.6
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.992 s

Cookies og privatliv